Targeting the cancer mutanome of breast cancer

Targeting the cancer mutanome of breast cancer, Published online: 04 June 2018; doi:10.1038/s41591-018-0065-z

A metastatic hormone receptor–positive breast cancer, usually resistant to immunotherapy, is successfully treated with tumor-infiltrating lymphocytes enriched for neoantigen reactivity, underscoring the broad potential of this immunotherapeutic approach.

中文翻译：

---

针对乳腺癌的癌症突变

针对乳腺癌的癌症突变

针对乳腺癌的癌症突变，在线发布：2018年6月4日; doi：10.1038 / s41591-018-0065-z

一种转移性激素受体阳性的乳腺癌，通常对免疫疗法有抵抗力，已通过富含肿瘤抗原的新抗原反应性淋巴细胞成功治疗，这突显了这种免疫治疗方法的广泛潜力。